| Jamie H Kiehm, MD | |
|
1680 E 120th St, Los Angeles, CA 90059-3026 | |
| (424) 338-8000 | |
| Not Available |
| Full Name | Jamie H Kiehm |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 13 Years |
| Location | 1680 E 120th St, Los Angeles, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508152810 | NPI | - | NPPES |
| 274101 | Other | NY | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 274101 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Andrew K. Wong, M.d., Inc. | 6406224567 | 3 |
News Archive
Previously published solar exposure guidelines for optimal vitamin D synthesis based on a study of skin samples may need to be revised, according to new research published today in PNAS.
Professor John Mayer and Dr Simon Dawson, in collaboration with colleagues at Japan's Kyoto University, have discovered the function of a new liver oncoprotein - or cancer causing protein - which could be the first step to finding effective new treatments for the deadly illness.
Despite many confrontations with the White House, Republicans have decided the best strategy is to focus this legal challenge on actions President Barack Obama has taken on the health law.
iCo Therapeutics Inc. (TSX-V: ICO) is pleased to announce that the company has signed a collaboration development agreement with The Consortium for Parasitic Drug Development (CPDD) for the research and development of iCo's oral drug delivery technology for the treatment of neglected diseases such as leishmaniasis and trypanosomiasis. Initial funding of USD $182,930 will be provided for formulation optimization for tropical conditions.
› Verified 5 days ago
| Entity Name | Andrew K. Wong, M.d., Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669144465 PECOS PAC ID: 6406224567 Enrollment ID: O20221121001574 |
News Archive
Previously published solar exposure guidelines for optimal vitamin D synthesis based on a study of skin samples may need to be revised, according to new research published today in PNAS.
Professor John Mayer and Dr Simon Dawson, in collaboration with colleagues at Japan's Kyoto University, have discovered the function of a new liver oncoprotein - or cancer causing protein - which could be the first step to finding effective new treatments for the deadly illness.
Despite many confrontations with the White House, Republicans have decided the best strategy is to focus this legal challenge on actions President Barack Obama has taken on the health law.
iCo Therapeutics Inc. (TSX-V: ICO) is pleased to announce that the company has signed a collaboration development agreement with The Consortium for Parasitic Drug Development (CPDD) for the research and development of iCo's oral drug delivery technology for the treatment of neglected diseases such as leishmaniasis and trypanosomiasis. Initial funding of USD $182,930 will be provided for formulation optimization for tropical conditions.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jamie H Kiehm, MD 1680 E 120th St, Los Angeles, CA 90059-3026 Ph: (424) 338-8000 | Jamie H Kiehm, MD 1680 E 120th St, Los Angeles, CA 90059-3026 Ph: (424) 338-8000 |
News Archive
Previously published solar exposure guidelines for optimal vitamin D synthesis based on a study of skin samples may need to be revised, according to new research published today in PNAS.
Professor John Mayer and Dr Simon Dawson, in collaboration with colleagues at Japan's Kyoto University, have discovered the function of a new liver oncoprotein - or cancer causing protein - which could be the first step to finding effective new treatments for the deadly illness.
Despite many confrontations with the White House, Republicans have decided the best strategy is to focus this legal challenge on actions President Barack Obama has taken on the health law.
iCo Therapeutics Inc. (TSX-V: ICO) is pleased to announce that the company has signed a collaboration development agreement with The Consortium for Parasitic Drug Development (CPDD) for the research and development of iCo's oral drug delivery technology for the treatment of neglected diseases such as leishmaniasis and trypanosomiasis. Initial funding of USD $182,930 will be provided for formulation optimization for tropical conditions.
› Verified 5 days ago
Dr. Robert W Eitches, Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 8631 W 3rd St, 925e, Los Angeles, CA 90048 Phone: 310-657-4600 Fax: 310-657-6020 | |
Renata G. Lubens, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 6041 Cadillac Ave, Los Angeles, CA 90034 Phone: 323-857-2000 | |
Dr. Barry Allen Kohn, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 7095 Hollywood Blvd, #635, Los Angeles, CA 90028 Phone: 323-436-0516 Fax: 323-436-0517 | |
Dr. Jean Marie Hanley, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 1801 E. Marengo St., L-902, Los Angeles County Usc Division Of Allergy, Los Angeles, CA 90033 Phone: 323-226-3823 Fax: 323-226-3732 | |
Richard M Harris, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1125 S Beverly Dr, Suite 740, Los Angeles, CA 90035 Phone: 310-275-0380 Fax: 310-275-1210 | |
Christina Hong Lee, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 11301 Wilshire Blvd, Bldg 500, 111r, Los Angeles, CA 90073 Phone: 310-478-3711 | |
Emily Hao-yun Liang, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 4733 W Sunset Blvd, 3rd Floor, Los Angeles, CA 90027 Phone: 323-783-4516 |